Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-06

Clinical Trial Update: Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methylphenidate formulations for cognitive functioning in brain tumor patients was terminated with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Tumor | Phase 3 | Status: TERMINATED | Results posted: 2011-05-06